Evidence map›Paper›PMID 26719975›Full record

ArticlePloS one2015

Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology.

Olga Perovic, Samantha Iyaloo, Ranmini Kularatne, Warren Lowman, Noma Bosman, Jeannette Wadula, Sharona Seetharam, Adriano Duse, Nontombi Mbelle, Colleen Bamford and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Mupirocin-resistantAntimicrobial resistance and infection control · 2018
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antimicrobial resistance and clonality ofFrontiers in microbiology · 2023
    Article
  9. Antimicrobial resistance profile of methicillin-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  10. Prevalence ofSouthern African journal of infectious diseases · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Human-Associated Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  16. Molecular Characterization ofInfection and drug resistance · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Olga PerovicNational Institute for Communicable Diseases at National Health Laboratory Service, Johannesburg, South Africa.
Samantha IyalooNational Institute for Communicable Diseases at National Health Laboratory Service, Johannesburg, South Africa.
Ranmini KularatneDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Warren LowmanDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Noma BosmanDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Jeannette WadulaDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Sharona SeetharamDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Adriano DuseDepartment of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Science, University of Witwatersrand, Johannesburg, South Africa.
Nontombi MbelleDepartment of Medical Microbiology at University of Pretoria, Pretoria, South Africa.
Colleen BamfordNational Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
Halima DawoodDepartment of Medicine, Greys Hospital and Caprisa, Pietermaritzburg, South Africa, University of KwaZulu Natal, Durban, South Africa.
Yesholata MahabeerNational Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Prathna BholaNational Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Shareef AbrahamsNational Health Laboratory Service, Stellenbosch, Stellenbosch University, Stellenbosch, South Africa.
Ashika Singh-MoodleyNational Institute for Communicable Diseases at National Health Laboratory Service, Johannesburg, South Africa.
National Health Laboratory Service · ZAChris Hani Baragwanath Hospital · ZAUniversity of the Witwatersrand · ZAGrey's Hospital · ZAGroote Schuur Hospital · ZAJohannesburg Hospital · ZAStellenbosch University · ZAUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe aimed to obtain an in-depth understanding on recent antimicrobial resistance trends and molecular epidemiology trends of S. aureus bacteraemia (SAB).

methodsThirteen academic centres in South Africa were included from June 2010 until July 2012. S. aureus susceptibility testing was performed on the MicroScan Walkaway. Real-time PCR using the LightCycler 480 II was done for mecA and nuc. SCCmec and spa-typing were finalized with conventional PCR. We selected one isolate per common spa type per province for multilocus sequence typing (MLST).

resultsS. aureus from 2709 patients were included, and 1231 (46%) were resistant to methicillin, with a significant decline over the three-year period (p-value = 0.003). Geographical distribution of MRSA was significantly higher in Gauteng compared to the other provinces (P<0.001). Children <5 years were significantly associated with MRSA with higher rates compared to all other age groups (P = 0.01). The most prevalent SCCmec type was SCCmec type III (531 [41%]) followed by type IV (402 [31%]). Spa-typing discovered 47 different spa-types. The five (87%) most common spa-types were t037, t1257, t045, t064 and t012. Based on MLST, the commonest was ST612 clonal complex (CC8) (n = 7) followed by ST5 (CC5) (n = 4), ST36 (CC30) (n = 4) and ST239 (CC8) (n = 3).

conclusionsMRSA rate is high in South Africa. Majority of the isolates were classified as SCCmec type III (41%) and type IV (31%), which are typically associated with hospital and community- acquired infections, respectively. Overall, this study reveals the presence of a variety of hospital-acquired MRSA clones in South Africa dominance of few clones, spa 037 and 1257. Monitoring trends in resistance and molecular typing is recommended to detect changing epidemiological trends in AMR patterns of SAB.

Indexed as

Methicillin ResistanceAdolescentAdultAgedAged, 80 and overAge DistributionBacteremiaChildChild, PreschoolGenotypeHospitalizationHumansInfantInfant, NewbornInhibitory Concentration 50Methicillin-Resistant Staphylococcus aureus

Identifiers

PMID26719975
PMCPMC4697812
OpenAlexW2200616451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.